Vertex Pharmaceuticals is not making its drug, Trikafta, available in poorer countries, where thousands of diagnosed patients stand to benefit.
This post first appeared in The New York Times – Business. Read the original article.‘Miracle’ Cystic Fibrosis Drug Kept Out of Reach in Developing Countries
The New York Times – Business:
Written by
in
